Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis
Not Applicable
Completed
- Conditions
- Cystic Fibrosis
- Registration Number
- NCT02883816
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
The main objective of this study is to show that there is a concordance between lung disease at 13 months and the existing 9 weeks in newborn babies with cystic fibrosis asymptomatically.
This will identify at the first examination at 8 weeks, newborns who have the most impaired lung function at 13 months. To meet this objective an assessment of their lung function at 9 weeks and 1 month will be performed in newborns diagnosed with cystic fibrosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change from respiratory function at 7 months and 11 months 7 months and 11 months measurement of lung volumes and flow rates of bronchial
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU Montpellier
🇫🇷Montpellier, France
CHU Montpellier🇫🇷Montpellier, France